chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain in the back of her legs; pain in her left arm; body aches; COVID-19; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Dec-2021 and was forwarded to Moderna on 30-Dec-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the back of her legs), VACCINATION SITE PAIN (pain in her left arm), MYALGIA (body aches) and COVID-19 (COVID-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: Pfizer vaccine (The patient received the Pfizer vaccine for her primary series of the vaccine.). Past adverse reactions to the above products included No adverse event with Pfizer vaccine.    On 28-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. In December 2021, the patient experienced COVID-19 (COVID-19). On 28-Dec-2021, the patient experienced PAIN IN EXTREMITY (pain in the back of her legs), VACCINATION SITE PAIN (pain in her left arm) and MYALGIA (body aches). At the time of the report, PAIN IN EXTREMITY (pain in the back of her legs), VACCINATION SITE PAIN (pain in her left arm), MYALGIA (body aches) and COVID-19 (COVID-19) outcome was unknown.            No concomitant medication and treatment information was reported.  Company Comment: This case concerns a female patient of unknown age with a history of tozinameran COVID-19 vaccine who experienced the unexpected adverse event of special interest of COVID-19 which occurred on an unknown date relative to vaccination with mRNA-1273 administered as a booster third dose. The benefit-risk relationship of mRNA-1273 is not affected by this report. Events' seriousness assessed as per Regulatory Authority reporting.; Sender's Comments: This case concerns a female patient of unknown age with a history of tozinameran COVID-19 vaccine who experienced the unexpected adverse event of special interest of COVID-19 which occurred on an unknown date relative to vaccination with mRNA-1273 administered as a booster third dose. The benefit-risk relationship of mRNA-1273 is not affected by this report. Events' seriousness assessed as per Regulatory Authority reporting.
Had a fever of 100.3 the day after shot, gave her some tylenol and she was fine afterwards. Later that night she started having red spots around the shot area, thought it was probably from the bandage. However as days went by the spota got bigger and spreading down and behind her legs. I took her to the doctor twice. First time they said ID reaction second visit they said she has erythema multiforme. This is actually the second time shes had a reaction to these shots. She broke out into hives in 2017.
tenderness, swelling, heat & watery-blister formation; blister approx 2-3" near or below site of inject; blister 1st noted on 31DEC93;
Severe Muscle pain in my shoulders, arms and back of thighs; my hand is completely numb; I can not lift anything and have no strength; I can not lift anything and have no strength; This is a spontaneous report from a contactable consumer (patient). A 53-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm right on 09Apr2021 (Lot Number: EP6955) as dose 1, single at 53-year-old for COVID-19 immunization. Medical history included no spleen, asthma, arthritis, many broken bones, and Penicillin or anything cillian allergy. Concomitant medications included montelukast sodium (SINGULAIR); fluticasone propionate, salmeterol xinafoate (ADVAIR); and naproxen sodium (ALEVE); all were taken for an unspecified indication, start and stop date were not reported. On 12Apr2021, the patient experienced severe muscle pain in shoulders, arms and back of thighs. It also has attached to her ulna nerve in right arm and his hand was completely numb. The patient cannot lift anything and have no strength, because the pain was so excruciating. The outcome of the events was not recovered. It was unknown if the patient received any treatment for the events. The events were assessed as serious (disability).  Follow-up attempts are completed. No further information is expected.
Patient returned to Health Center at 1:15 PM with complaint of throat feeling swollen since 11 AM. No shortness of breath/difficulty breathing. Vital signs stable. BENADRYL 50 mg IM given at 1:34 PM. Patient observed and reported resolution of throat swelling sensation.
Pt had his last set at 12 mos and shut down at 14 mos regressed have him on video at 12 mos clapping and saying yes and after 14 mos on video diagnosed PDD at 22 mos had urine test for mercury done results as of 7/18/03 very highly elevated and has twice the maximum amount of mercury in him. My sister noticed him at 6 mos not developing but never mentioned it to me until he was diagnosed.
Approximately 2-3 weeks after vaccine, patient became short of breath while walking at work. By week 3, couldn't talk full sentences. Labs revealed critical d-dimer and CT revealed BL PE's in subsegmental areas.
Patient presented 2 days after receiving SHINGRIX with a red rash approximately 2 inches in diameter that was hot to the touch. The area was outlined and the patient was told to seek further help if the rash grew due to the possibility of cellulitis. She was given BENADRYL for an allergic reaction.
Report  chills and fever of 101.8 7:30 pm that evening. Treatment: Advil, Outcome: complete resolution of symptoms the next morning.  Did not interfere with ADLs.
Severe cramping in her left leg; Pain in arm occassionally; Sharp pain above the heart occassionally; Bad nightmares; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (Bad nightmares), MUSCLE SPASMS (Severe cramping in her left leg), PAIN IN EXTREMITY (Pain in arm occassionally) and CHEST PAIN (Sharp pain above the heart occassionally) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J202A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jan-2021, the patient experienced NIGHTMARE (Bad nightmares). On an unknown date, the patient experienced MUSCLE SPASMS (Severe cramping in her left leg), PAIN IN EXTREMITY (Pain in arm occassionally) and CHEST PAIN (Sharp pain above the heart occassionally). At the time of the report, NIGHTMARE (Bad nightmares), MUSCLE SPASMS (Severe cramping in her left leg), PAIN IN EXTREMITY (Pain in arm occassionally) and CHEST PAIN (Sharp pain above the heart occassionally) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Case number PHEH2013US010972, is an initial spontaneous report received from a nurse on 15 MAY 2013. This report refers to an 18-year-old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: X12013) intramuscularly on 15 MAY 2013. He received only MenCWY-135 liquid conjugate component, instead of being reconstituted with MenA lyophilized conjugate vaccine of MENVEO. No adverse reaction reported.
10:30 am patient complaint of dizziness and stiffness in back of neck. BP 110/70, P 72, R 18, O2 sat 98% room air.
The next day I started out with a normal sore arm feeling in my left arm as with any vaccine.   By two days later I was having pain and swelling in my left arm pit and side of my left breast causing discomfort and worry.   I read online that swollen lymphnodes post vaccine can be normal but I have never had this reaction with my first two moderna vaccines, nor did I have it with my first booster dose.   I do plan on bringing this to my primary care providers attention on 08/08/2023 at an appointment I had previously scheduled for other health issues just to make sure I seem ok otherwise.
Approximately 30 minutes following injection, I developed a severe migraine with mild dysequilibrium for which I took my prescribed medication.  Around 7:00pm that evening, I noticed a decrease in ability to taste and smell. By the next morning, I had no sense of taste or smell. When the symptoms did not resolve by Wednesday, I called my primary care doctor who advised that I take a COVID-19 test.  I did go to a Clinic for the rapid test, which was negative.  When I informed my PCP of the result, I was instructed to report the symptoms as a side effect of the vaccine. I still have not regained my sense of smell or taste.
Right supraclavicular adenopathy and right axillary adenopathy continues. Contacted  PCP and Allergist and was told to take Benadryl and watch for 2 weeks. Also experienced  chills, body aches, nausea & diarrhea that have resolved.
approx 5 days after vaccination, pt states he developed itching and swelling around left ear, that then spread left side of arm over the last few days. Lesions were without vesicles or drainage, primarily raised red lesions related to hives. He visited dermatologist who rx'ed antihistamines, benadryl and OTC hydrocortisone. Denies anaphylactic reaction with no SOB, respiratory distress, swelling of tongue, mouth, eyes or lips. As of now, he is no longer itchy but with rash still present. He will have f/u on 3/8 with dermatologist for final opinion about whether he can receive his next vaccine as scheduled on 3/11/21.
injection was given with just adjuvant, no powder was mixed; injection was given with just adjuvant, no powder was mixed; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 97-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced inappropriate preparation of medication (Verbatim: injection was given with just adjuvant, no powder was mixed) and inappropriate dose of vaccine administered (Verbatim: injection was given with just adjuvant, no powder was mixed). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 23-Oct-2023 The reporter calling to get a replacement. The reporter did not consent to follow-up. The patient was given Shingrix injection with just adjuvant, no powder was mixed, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
12 hours of cold chills; 18 hours of excruciating headache; nausea; vomiting. Dull headache the next day.
Patient possibly inadvertently received 1cc of Moderna COVID vaccine instead of 0.5cc. Patient was notified. State was notified
08:25 vaccine given, 2 min. after pt c/o dizziness and nausea but never lost conscious. Lying pt down with legs up, V/s taken BP 106/67 P69 lying at 08:47,  BP 114/76 sitting P 70 at 08:50. Pt stated feeling better with lying down. 09:00 Pt stated feeling better, no more dizzy or nausea.
T101; on 07/16 10AM developed hives on legs, arms, thighs. Acting fine. Resolved without intervention in less than 2 hours.
The above vaccine was a booster. I became infected with a cold sore (herpes) on my upper lip and lower lip (both are places where these things have appeared in the past, however, it has been over a decade since I have had both at the same time and years since I have had any outbreak.  I also have genital herpes which I also have an outbreak. I have not had an outbreak here in around a decade as well.  I also got shingles for the first time after the second vaccine almost a year ago which I will document at this time.
Pt recv vax on 10/29/98; on 10/30/98 pt exp shortness of breath, wheezing & hives; tx=Albuterol, Epinephrine, Solumedrol, Benadryl, Tagamet, Ventolin inhaler
On 5/31/08 left lower arm where varicella vaccine placed was red and hot, 3 3/4" width and 3 1/4 " length. Doctor said local reaction. Father stated it was worse before and better now.
Hives -went home after vaccine administered, took nap and awakened 2 hours later covered in hives. House staff called and patient taken to ER and treated. given Benadryl 23 mg 1 or 2 every 6-8 hours and Zantac 150 BID X 10 days. Still have hives 12/04/01 had history of Hepatitis A disease Vaccine given as requirement for work.
5cm of erythema redness at site of injection, mild tenderness. Treated with ice, Benadryl prn, Ibuprofen prn.
excessive tinnitus.   have had tinnitus for 5 years and it is very managable using a masker.  This tinnitus has become so much more excessive it reminds me of my first diagnosis.  reaction began 4/26 and continues to this day o f 5/3 I have also been experience unusual dizziness and nausea; I was in bed for 2 days and stiff suffering but I have to go to work .  I did not make the connection with the vaccine until today.
This case was reported by a consumer via call center representative and described the occurrence of joint pain in a 71-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included Flu vaccine (received on an unknown date). On 4th January 2019 09:30, the patient received the 1st dose of SHINGRIX (intramuscular). On 4th January 2019, unknown after receiving SHINGRIX, the patient experienced vaccine administered at inappropriate site. On 4th January 2019 16:00, the patient experienced joint pain, injected limb mobility decreased, injection site pain, rotator cuff injury and muscle pain. The patient was treated with TYLENOL EXTRA STRENGTH. On an unknown date, the outcome of the joint pain and injected limb mobility decreased were not recovered/not resolved and the outcome of the injection site pain, rotator cuff injury, muscle pain and vaccine administered at inappropriate site were unknown. It was unknown if the reporter considered the joint pain, injected limb mobility decreased, injection site pain, rotator cuff injury and muscle pain to be related to SHINGRIX. Additional details were provided as follows: The patient received 1st dose of SHINGRIX on 4th January 2019 around 9:30 AM and around 4:00 - 5:00 PM, the patient experienced joint pain, injection site soreness and movement of left arm was inhibited. The patient claims that the pain is not normal muscle pain from an immunization injection. The pain has moved to her left pectoral muscle above her left breast. The described the pain as similar to a rotator cuff injury in the joint. The patient received sleep aid medication. The patient can move her arm with less pain after receiving TYLENOL EXTRA STRENGTH. The patient was concerned that the pharmacy administered the vaccine too high in her deltoid or in the joint. The patient had to take some medication to help her sleep because she couldn't move and she wants to go back to playing yoga and tennis because she is a very active senior.
Nausea, vomiting, and body aches within 3 hrs of injection. Swelling and pain at injection site. Cellulitis at injection site, L armpit, L breast, lymph nodes, L shoulder.  Prescribed antibiotics and instructed to take OTC NSAIDS and Anti-hystamimes. If symptoms don't abade seek further treatment, possibly IV antibiotics.
episode of intense crying x 10 minutes, limp, blue then fell asleep but had returned to nl status;
I had shingles, shot and shingles the third time/ suspected vaccination failure; I had shingles, shot and shingles the third time.; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an adult patient who received Herpes zoster (Shingle's vaccine).   On an unknown date, the patient received Shingle's vaccine. On an unknown date, unknown after receiving Shingle's vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingle's vaccine.  Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported. The age group was not reported but was selected as adult as per vaccine indication. The patient had shingles shot and had shingles the third time. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for target disease and laboratory confirmation were unknown at the time of reporting.
Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch (specify: facial area, extremeties)-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Mild, Additional Details: Patient showed signs of anxiety starting before injection
I have been having issues for years and it took a lot of money and doctors to find out what was going on. Finally after cysts rupturing I went to the ER. After speaking with other people my age who also have been diagnosed I found the common denominator of GARDASIL. It is a painful and ongoing struggle that has cost me thousands of dollars, time from work, and emotional trauma.
SLEEP  mostly all two days, chills, skin "hurts", don't eat, lost 5 pounds, resting heart rate 55 whereas normal is 45
Red spots on his forearms and tummy; Sick (left work mid-Day); In bed all day; Could Not Swallow Anything; Tired; Lungs Hurting; Burning Sensation in the Lungs; Throat and tongue hurting; Throat and tongue hurting; This spontaneous case was reported by a consumer and describes the occurrence of PULMONARY PAIN (Lungs Hurting), BURNING SENSATION (Burning Sensation in the Lungs), OROPHARYNGEAL PAIN (Throat and tongue hurting), GLOSSODYNIA (Throat and tongue hurting) and ILLNESS (Sick (left work mid-Day)) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy NOS and Asthma. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY), MONTELUKAST, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR UNSPEC) and FLUTICASONE for an unknown indication.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PULMONARY PAIN (Lungs Hurting), BURNING SENSATION (Burning Sensation in the Lungs), OROPHARYNGEAL PAIN (Throat and tongue hurting), GLOSSODYNIA (Throat and tongue hurting), DYSPHAGIA (Could Not Swallow Anything) and FATIGUE (Tired). On 07-Apr-2021, the patient experienced ILLNESS (Sick (left work mid-Day)) and ASTHENIA (In bed all day). On 08-Apr-2021, the patient experienced ERYTHEMA (Red spots on his forearms and tummy). On 13-Apr-2021, ERYTHEMA (Red spots on his forearms and tummy) outcome was unknown. On 14-Apr-2021, PULMONARY PAIN (Lungs Hurting), BURNING SENSATION (Burning Sensation in the Lungs), OROPHARYNGEAL PAIN (Throat and tongue hurting), GLOSSODYNIA (Throat and tongue hurting), ILLNESS (Sick (left work mid-Day)), ASTHENIA (In bed all day), DYSPHAGIA (Could Not Swallow Anything) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment was Zyrtec, Advair disc inhaler  Consent received to save the caller's information wit in our database and for safety to follow up 27-APR-2021   Reporter did not allow further contact
Pfizer 4/12 and 5/3. Positive on 1/3
This spontaneous report as received from a licensed practice nurse refers to a multiple unspecified patients of unknown age and gender. No information regarding concurrent condition and medical history was reported. On an unknown date the multiple unspecified patients were vaccinated with PEDVAXHIB (strength, dose, unit, lot number, expiry date and route were unknown) which was stored improperly. No concomitant therapy was reported. No adverse event was reported. The outcome of event was unknown. No further information was provided. This is one of several reports received from the same source. Additional information is not expected.
Information has been received from a physician concerning a 9 yr old female who on 18Aug97 was vaccinated with a 0.5mL dose of varicella virus vaccine live (lot 622969/0423E). There was no concomitant medication. On 13Dec05 the pt developed a mild case of breakthrough varicella (less than 50 lesions). She did not have a fever. No other details were given. The outcome was reported as recovering. There were no lab diagnostic studies performed. Additional information has been requested.
Blood and mucus in stool, abdominal pain - Oct/Nov/Dec 2022 January 2, 2023 - rapid onset and urgent diarrhea followed by dehydration and severe abdominal pain January 8 and 9 - ER visits. CT Scan shows ulcerative colitis. Full panel of tests completed including stool sample to rule out bacterial and viral infections.  January 10 - hospitalized January 11 - colonoscopy confirms severe pancolitis ulcerative colitis
It started with a cough, and it lasted for about 8 days. I had a runny nose for about 5 days. I had a sore throat for about 2 days. I had fatigue for about 7 days. I was taking cold medication until I went to the clinic and got Paxlovid.
swelling, heat, redness, itching, pain at injection site with onset 7 days after injection.
doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses were given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  The vial was placed in the refrigerator on 04-NOV-2021. Vial did not undergo any temperature excursion. No adverse event was reported.  No treatment medications were reported.
Approximately 5 days after receiving vaccine I woke at 6:30am to an itchy scalp. As the day progressed my skin became increasingly hot and felt like a sunburn. It is itchy all over and has developed to blotches all over my skin. The heat and burning feeling is also all over.